Aether Bio

Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Aether Bio headquartered in United States, North America, operates in the Artificial Intelligence (AI), Machine Learning, Medical sector. The company focuses on Artificial Intelligence (AI) and has secured $5.9B in funding across 120 round(s). With a team of 11-50 employees, Aether Bio is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - Aether Bio, raised $49.0M. Discover more about their projects, partnerships, and impact on our platform.